Knowledge Tree
Relations (1)
cross_type 1.00 — strongly supporting 4 facts
The U.S. is identified as a location where ketamine is a legally prescriptible treatment for treatment-resistant depression, as established in [1].
Facts (4)
Sources
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 2 facts
claimThe clinical growth of at-home ketamine care models was partially accelerated by the relaxation of telehealth prescribing rules in the United States during the COVID-19 pandemic.
referenceBrendle et al. (2022) analyzed the cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the United States, utilizing clinical trial efficacy and real-world effectiveness estimates.
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com 2 facts
claimKetamine is a prescriptible treatment for treatment-resistant depression (TRD) in the USA and Israel, with many other countries implementing this treatment, according to Mathai et al. (2020).
measurementThe United States produced the highest number of studies on psychedelics (n = 18) in the analyzed sample, with a primary focus on ketamine (n = 7) and cannabinoids (n = 4).